
OrthoPulse is an approved near-infrared medical device, FDA cleared and EU MDR approved, that shortens orthodontic treatment and reduces pain.
orthopulse.comCrawled Nov 2, 2026
OrthoPulse uses near-infrared light to speed up tooth movement, shorten treatment time, and improve patient comfort.
Here you can find the IFU for the OrthoPulse device in all languages.
OrthoPulse is a clinically proven medical device, FDA cleared, that utilizes exclusive, patented Near-Infrared Light Technology to stimulate the bone surrounding the roots of teeth.
The OrthoPulse Education Series presents U.S. clinicians discussing clinical insights, treatment protocols, and the science of near-infrared light orthodontics.
OrthoPulse lite competes in the AAO 2026 New Product Showcase Award for advancing light-accelerated orthodontics. As the only FDA-cleared near-infrared light device in orthodontics, it ensures planned tooth movement and reduces treatment time and discomfort.
OrthoPulse lite, featured at AAO 2026, provides near-infrared photobiomodulation to support faster tooth movement and improved treatment predictability, backed by real-world data.
Preliminary data from an ongoing single-practice clinical study by Dr. Bella Shen Garnett demonstrates reduced treatment time, fewer refinements, and fewer office visits.
Single-practice analysis reports 21% fewer office visits, 55% shorter treatment time, and 25% fewer finishing aligners
New initiative helps practices standardize OrthoPulse across aligner workflows to reduce refinements, improve treatment efficiency, and enhance patient experience.
OrthoPulse accelerates treatment by up to 50% and reduces pain by up to 73%.
OrthoPulse is the first and only approved medical device that uses near infrared light technology to shorten treatment time and reduce pain associated with orthodontic treatment.
OrthoPulse is the first and only approved medical device that uses near infrared light technology to shorten treatment time and reduce pain associated with orthodontic treatment.
Biolux Technology explains privacy rights and processes for handling requests related to the sale or sharing of personal information.
Biolux Technology’s Privacy Policy describes how information is collected, used, and disclosed through the OrthoPulse device, app, and Dr. Portal, collectively called the OrthoPulse System.
Biolux Technology’s privacy policies for OrthoPulse detail how personal information is handled across the website, mobile app, device, and Dr. Portal.
Biolux Technology’s Privacy Policy outlines how personal information is collected, used, and disclosed on www.orthopulse.com and related communications.
Legal information of Biolux Technology GmbH, an Austrian medical device company based in Absdorf, specializing in the trade and distribution of medical devices.
Biolux Technology introduces **OrthoPulse lite**, a new light-based orthodontic treatment platform designed for broader accessibility in patient care and dental practices. The system aims to redefine orthodontic therapy standards by leveraging light-enabled technology. The launch positions Biolux as a pioneer in integrating advanced orthodontic solutions into mainstream practice.
Biolux Technology secures a **$4.5 million seed funding round** from redalpine and Revere Partners to advance its light-accelerated orthodontic solutions. The company plans to develop a **smart digital platform** for its OrthoPulse® product, enabling real-time treatment monitoring for orthodontists and patients. This investment supports the expansion of Biolux’s technology in the orthodontic market.
Biolux Technology introduces OrthoPulse, its orthodontic optimization platform, to the U.S. market with an enhanced version backed by clinical evidence. The product aims to deliver reliable solutions for dental and orthodontic professionals. This launch represents a key step in the company’s expansion and innovation in orthodontic technology.
Biolux Research secures FDA clearance for its OrthoPulse orthodontic treatment system. The device integrates advanced light-based technology to accelerate tooth alignment processes. This clearance enables the company to market OrthoPulse as a safe and effective solution for orthodontic practitioners.
Biolux Research launches OrthoPulse™, a CE-marked Class 2A orthodontic device now available across Europe. The product secures approval under the Medical Device Directive 93/42/EEC via the British Standards Institute. This marks the commercial debut of OrthoPulse™ in markets recognizing CE certification.